Novo Nordisk (Privately Held; Venture Capital & Private Equity industry): Vice President, (August 2005-Present) Head of Inflammation Biology. Identifies drug targets and new project opportunities for treatment of chronic inflammatory dieases. Validating targets and lead prot...
Linkedin